4//SEC Filing
Leverone Jason A. 4
Accession 0001209191-19-047367
CIK 0001590750other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 6:16 PM ET
Size
7.4 KB
Accession
0001209191-19-047367
Insider Transaction Report
Form 4
Leverone Jason A.
CFO, Treasurer & Secretary
Transactions
- Exercise/Conversion
Common Stock
2019-08-23$0.57/sh+3,093$1,763→ 36,330 total - Exercise/Conversion
Stock Option (right to buy)
2019-08-23−3,093→ 0 totalExercise: $0.57Exp: 2019-09-23→ Common Stock (3,093 underlying)
Footnotes (2)
- [F1]Includes 1,250 shares acquired under the Miragen Therapeutics, Inc. 2015 Employee Stock Purchase Plan on February 22, 2019.
- [F2]The option is fully vested and exercisable. The option expires ten years after the date of grant.
Documents
Issuer
MIRAGEN THERAPEUTICS, INC.
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001692747
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 6:16 PM ET
- Size
- 7.4 KB